|1.||Wilson, Kumanan: 1 article (12/2015)|
|2.||Attaran, Amir: 1 article (12/2015)|
|3.||Sridhar, Saranya: 1 article (09/2015)|
|4.||Berkowitz, Nina M: 1 article (04/2015)|
|5.||Sitar, Sandra: 1 article (04/2015)|
|6.||Robb, Merlin L: 1 article (04/2015)|
|7.||Stanley, Daphne: 1 article (04/2015)|
|8.||Graham, Barney S: 1 article (04/2015)|
|9.||Enama, Mary E: 1 article (04/2015)|
|10.||RV 247 Study Team: 1 article (04/2015)|
11/01/2011 - "Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy."
01/01/2015 - "In this review, we describe the origin and structure of ebolaviruses and the development of vaccines from the beginning of the 1980s, including conventional ebolavirus vaccines, DNA vaccines, Ebola virus-like particles (VLPs), vaccinia virus-based vaccines, Venezuelan equine encephalitis virus (VEEV)-like replicon particles, Kunjin virus-based vaccine, recombinant Zaire Ebolavirusx2206;VP30, recombinant cytomegalovirus (CMV)-based vaccines, recombinant rabies virus (RABV)-based vaccines, recombinant paramyxovirus-based vaccines, adenovirus-based vaccines and vesicular stomatitis virus (VSV)-based vaccines. "
|3.||Ebola Hemorrhagic Fever
09/01/2015 - "The ongoing outbreak of Ebola virus disease in West Africa highlighted the lack of a licensed drug or vaccine to combat the disease and has renewed the urgency to develop a pipeline of Ebola vaccines. "
04/18/2015 - "These findings have contributed to the accelerated development of more potent Ebola virus vaccines that encode the same wild-type glycoprotein antigens as the EBO vaccine, which are being assessed during the 2014 Ebola virus disease outbreak in west Africa. "
|4.||Wounds and Injuries (Trauma)
|2.||Synthetic Vaccines (Recombinant Vaccines)